Taken together, our data demonstrate that PhKh1 cells have an aggressive phenotype, recapitulate features of the tumor of origin, and can be therefore used as an in vitro model to study HGNET-BCOR biology and to perform preclinical tests. The gene discussed is BCOR; the disease is neoplasm.